NCT06268951Enrolling by invitation
Recovery and Symptom Relief Following Percutaneous Ablation of Abdominal Wall Endometriosis
Source: ClinicalTrials.gov · Last updated 2 Jun 2026
Brief summary (registry, in English)
To determine the characteristics of recovery and symptom relief following ablation of abdominal wall endometriosis.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 13 Feb 2024
- Start date
- 9 May 2024
- Primary completion date
- 29 Feb 2028
- Lead sponsor
- Mayo Clinic
- Diseases
- Endometriosis
- NCT number
- NCT06268951
What you commit to
- Study type: Observational
- Planned participants: 50
- From 9 May 2024 to the primary completion date, 29 Feb 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Decline to participate in research.
Who the study is looking for
- Undergoing ablation for abdominal wall endometriosis.
Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.